Nvidia Aims to Simplify AI Adoption Process for Cincinnati Children’s, UCSF

Nvidia Aims to Simplify AI Adoption Process for Cincinnati Children’s, UCSF

Nvidiaa company primarily known for gaming, is hoping to bring its computer vision and AI tools to healthcare by designing graphics processing units that can serve as the basis for many medical AI technologies. The technology company unveiled new tools to accelerate AI in healthcare on Monday at RSNA 2022the annual radiology and medical imaging … Read more

AstraZeneca Puts Up $200M in Solid Bet on Startup’s Take on Cancer Cell Therapy

AstraZeneca Puts Up 0M in Solid Bet on Startup’s Take on Cancer Cell Therapy

Cell therapy has broken new therapeutic ground, but the progress of this drug class in blood cancers has yet to be realized in solid tumors. Big pharmaceutical companies and upstart biotechs are trying various approaches to broaden the scope of these cancer treatments and AstraZeneca is now joining them by buying a startup with technology … Read more

A multifaceted approach to improve cancer treatment and care

A multifaceted approach to improve cancer treatment and care

As a member of the cancer research community who has dedicated her professional career to studying and fighting cancer, I am starkly aware of the devastating impact of this disease as it continues to be the second leading cause of death globally. At the same time, I am incredibly encouraged by the work being done … Read more

2 Changes Siddhartha Mukherjee Is Calling for in Cancer Care

2 Changes Siddhartha Mukherjee Is Calling for in Cancer Care

Earlier this year, President Joe Biden revived Cancer Moonshota lofty effort to tackle the disease that is currently the second leading cause of death in the US The initiative seeks to reduce the country’s cancer death rate by at least half over the next 25 years, as well as “improve the experience of people and … Read more

Roche Withdraws Immunotherapy in US for Bladder Cancer After Failed Study

Roche Withdraws Immunotherapy in US for Bladder Cancer After Failed Study

Roche drug Tecentriq has become a blockbuster product with approvals spanning several types of cancer. Bladder cancer will no longer be one of them. The pharma giant is pulling the product from the US in that indication after it failed a study needed to retain its approval status. In a statement issued Tuesday, Roche said … Read more

Hospitals Can’t Afford to Lag Behind on Cloud Adoption, Microsoft Exec Argues

Hospitals Can’t Afford to Lag Behind on Cloud Adoption, Microsoft Exec Argues

Historically, healthcare has trailed other industries when it comes to the adoption of new technology — often by decades. But providers that fail to get serious about bucking this trend are putting their businesses at risk of closure. That was the message from John Barto, Microsoft‘s chief digital transformation officer for its health and life … Read more

CinCor Hypertension Drug Flunks Study, But the Biotech Still Sees a Phase 3 Path

CinCor Hypertension Drug Flunks Study, But the Biotech Still Sees a Phase 3 Path

A CinCor Pharma drug intended to offer a novel alternative to currently available hypertension treatments has failed a Phase 2 study. Nevertheless, CinCor points to better results in a pre-specified subgroup of patients representative of many hypertension patients. While the biotech firm contends the data will guide the design of a study that could support … Read more

KFF: Many Women Don’t Receive Paid Parental Leave Benefit From Employers

KFF: Many Women Don’t Receive Paid Parental Leave Benefit From Employers

Fewer than half of female workers receive a paid parental leave benefit from their employer, recently report shown. This includes maternity leave (43%) and family and medical leave to care for a sick family member (44%). The Kaiser Family Foundation (KFF) report comes from the 2022 KFF Women’s Health Survey, which focused on contraception, barriers … Read more

Declarations Aren’t Enough. Health Equity Needs Action, Healthcare Execs Say

Declarations Aren’t Enough.  Health Equity Needs Action, Healthcare Execs Say

Ask a healthcare organization what its top priority is today, and many will say health equity. But when it comes to creating real change, paying lip service won’t cut it, one executive said. “It’s virtue signaling,” said SCAN Health Plan CEO Sachin Jain in a recent interview. “It’s fashionable to say you care about this. … Read more

Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for Rare Lung Cancer

Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for Rare Lung Cancer

A Spectrum Pharmaceuticals drug developed to treat a rare type of lung cancer has been rejected by the FDA, leading the biotech company to implement an immediate restructuring that will reduce headcount by 75%. The regulatory decision announced on Friday came two months after an independent FDA advisory committee voted that the benefits of the … Read more